Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study

Background. Peripheral arterial disease (PAD) and its relevant complications are more common in hemodialysis (HD) patients, while the evidence regarding antiplatelet therapy in CKD patients is scarce. We retrospectively analyzed the efficacy of cilostazol on outcomes in HD patients with asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Paik Seong, Jeng, Yachung, Wu, Ming Ying, Pai, Mei-Ann, Wu, Tsai-Kun, Chen, Chang Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055930/
https://www.ncbi.nlm.nih.gov/pubmed/27747241
http://dx.doi.org/10.1155/2016/8236903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055930/
https://www.ncbi.nlm.nih.gov/pubmed/27747241
http://dx.doi.org/10.1155/2016/8236903

Ejemplares similares